Company profile

Newtrace

Electrode technology for lower-cost alkaline green hydrogen.

What They Build

Newtrace develops Voltagen, a proprietary electrode technology for alkaline water electrolysers designed as a drop-in replacement for OEMs, project developers, and industrial gas customers.

Why They Matter

Green hydrogen's cost problem lives partly inside electrolyser efficiency and lifetime. Newtrace matters because it attacks the electrode layer rather than the whole stack, which could make adoption easier if performance holds. Commercial deliveries will show whether the materials claim survives customer qualification.

Founders

Public founder details limited

Recent Milestones

  • Voltagen electrode technology disclosed for alkaline water electrolysers
  • About $12M total funding raised
  • $6.3M pre-Series A closed in March 2026, led by HDFC Bank and Mitsui Sumitomo Insurance Venture Capital
  • 30,000 sq ft Bengaluru facility employing 45+ engineers and scientists disclosed
  • Commercial Voltagen electrode deliveries planned within 12 months of the March 2026 funding close

Nearby signals

Related companies.